JPRN-UMIN000049367
Recruiting
N/A
Preventing Aggravation of Life-Style Diseases by Supporting Patients' Changing Behaviors at Community-Pharmacies. - Preventing Aggravation of Life-Style Diseases by Supporting Patients' Changing Behaviors at Community-Pharmacies.
iigata University of Pharmacy and Applied Life Sciences0 sites50 target enrollmentOctober 30, 2022
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- iigata University of Pharmacy and Applied Life Sciences
- Enrollment
- 50
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Pharmacotherapy less than 6 months
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
N/A
aughter on prevention of life-style related diseases and its complication: a randomized intervention studyMetabolic syndrome, hypertension, diabetes mellitus, dyslipidemia, obesityJPRN-UMIN000050645Fukushima Medical University500
Completed
N/A
Study on the lifestyle-related disease protective efficacy by an intake of Kombunot applicable_Healthy volunteersJPRN-UMIN000008240Metabolomics research, Kobe University Graduate School of Medicine30
Recruiting
Phase 3
Impact of lifestyle modification on the development of dementia, chronic kidney disease, diabetes and cardiovascular disease in a Thai general populatioDementiaChronic kidney disease stage 3Type 2 diabetes mellitus CancersCOPDCardiovascular diseaseDementiaChronic kidney disease stage 3Type 2 diabetes mellitusCancersCOPDCardiovascular diseaseTCTR20161116001Health Systems Research Institute3,600
Completed
N/A
A study on the prevention of lifestyle-related diseases in the elderly peoplehealthy adultsJPRN-UMIN000018125Tokushima University Hospital100
Recruiting
N/A
ifestyle modification for Prevention of non-communicable disorders: Intervention phase of the Tehran Lipid and Glucose Study (phase II)ifestyle modification interventions in preventing or postponing the development of NCD risk factors and outcomes with special focus on angina pectoris, myocardial infarction, cerebrovascular events, diabetes mellitus, hypertension and dyslipidemia..IRCT138705301058N1research institute for endocrine sciences15,005